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Thus, sources of inaccuracy may be related to variations in the levels of vitamin D binding protein (5) and cross-reactivity to 24,25-dihydroxyvitamin D (6) . Therefore, a number of laboratories introduced liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for the quantification of 25(OH)D (reviewed in (7)). Moreover, global standardization is advanced with LC-MS/MS reference methods (8;9) and the availability of NIST reference material (10) . Films were from Sigma Aldrich (München, Germany).
Application of LC-MS/MS

Calibrators and quality controls
Assay validation was performed with serum controls MassCheck® 3-epi-25-OH-D3/D2 and 25-OH-D3/D2 Level I (medium) and II (high) ( 
Sample preparation
Liquid-liquid extraction was used as described by Midttun et al. (17) . 
LC-MS/HR-MS:
25 ( (Table 1) within ±5ppm mass window, generates calibration lines (Figures S-4 to S-7), checks quality controls and ion ratios of quantifier to qualifier ions (Table   1) .
Method validation
Method validation was performed on the basis of the FDA (18) and EMA (19) guidelines on bioanalytical method validation (for details see Supplemental Data). 
Results
Specificity and matrix effects
The specificity of the method was investigated using qualifier ions ( data not shown). Moreover, ion ratios are evaluated for all patient samples during routine diagnostic with an acceptance criterion of ±20% as the maximum relative deviation. We only observed a failure of the ion ratio criterion for concentrations close to LoQ due to qualifier intensities at or below LoD (signal dropout of qualifier ions was partly due to a mass shift outside of the 5ppm mass window).
Similarly, matrix effects were evaluated in patient samples with potential interferences at low and high spike concentrations. For all patient samples the ISnormalized matrix factor was within a window 100±15% (data not shown). 
Calibration
Limit of quantification (LoQ)
Determination of LoQ for LC-MS/MS usually involves calculation of signal to noise ratios. Due to its high specificity we did not observe baseline noise in LC-MS/HR-MS for 25(OH)D species. Therefore, LoQ was determined by functional testing with serial dilutions of control and calibrator samples ( Figure S-8) . LoQ for all analytes were found below 10nmol/l (Table 1) . Typically, signals below the LoQ showed signal dropouts due to reduced mass precision and target masses outside the 5ppm mass window as shown for 25(OH)D 2 ( Figure 1B ).
Imprecision and trueness
Commercial serum controls traceable to NIST 972a reference material were used to evaluate imprecision and trueness including a low level prepared by dilution with physiological human albumin solution. For medium and high levels CVs were below 10% and trueness between 90 and 110% for all analytes ( Table 2 (Table S-2) .
Epimer fractions in patient samples
The fraction of 3-epi-25(OH)D 3 related to total 25(OH)D was calculated in patient samples submitted to routine diagnostics at the University Hospital Regensburg ( Figure 2 ). As expected children below 1 year displayed the highest fraction with a median of 14% and a maximum over 30% (Figure 2A ). An age-dependent decrease was observed with a median of 4.3% in adult patients. The fraction of epimer detected in patients of the University Hospital Regensburg fits very well to literature data (13;14) . Previous studies observed a median of 3 to 6% of the 3-epi-25(OH)D 3 -fraction in adult patients which is in good agreement to 4.3% found in our patients ( Figure 2B ).
In conclusion, the presented method shows for the first time the feasibility of LC-MS/HR-MS for small molecule quantification in laboratory routine testing. The high specificity of this technique may be also useful for other analytes as for example steroid hormone quantification. Extracted ion chromatograms (unsmoothed; quantifier ions as displayed in Table 1) are shown for A) a quality control sample (medium level, see Table 2 
